 Furosemide absorption patients cirrhosis patients cirrhosis mild severe intravenous oral furosemide random order absorption disposition Total serum clearance ml/min volume distribution elimination half-life minutes similar healthy control subjects patients cirrhosis Bioavailability range comparable previous studies difference patients mild severe cirrhosis patients mean absorption time mean residence time intravenous administration patients versus minutes furosemide flip-flop model patients patients mean absorption time relative normal subjects irrespective presence edema absorption furosemide edematous states congestive heart failure cirrhosis consequence edema se similar changes patients congestive heart failure diseases diverse pathophysiology furosemide absorption